Teva Executive and Leadership Team

Marija Bubanja, the Chief Financial Officer at Teva, directs the overarching fiscal strategy and capital allocation processes for the entire organization. By overseeing global financial reporting and long-term investment planning, the Chief Financial Officer ensures the company maintains a robust balance sheet capable of supporting complex pharmaceutical research. This leadership role involves constant collaboration with the Board to optimize resource distribution across diverse therapeutic portfolios. Marija Bubanja directly influences the financial health of the enterprise by implementing rigorous cost-management frameworks and revenue-growth initiatives. Through the integration of advanced data analytics, the Chief Financial Officer monitors market volatility and adjusts fiscal policies to protect shareholder value. Ultimately, the Chief Financial Officer secures the necessary capital to fuel the development of innovative medicines and maintain the competitive edge of the company within the global biopharmaceutical landscape.

Alexander Joramsa, the Chief Financial Officer (Asia Pacific, Japan) at Teva, directs all financial operations and fiscal planning across the critical Asia Pacific and Japanese markets. By overseeing regional budget management and local regulatory compliance, the Chief Financial Officer (Asia Pacific, Japan) ensures that the company maintains sustainable growth in these high-potential territories. This leadership role involves navigating complex economic environments to support the distribution of generics and innovative therapies. Alexander Joramsa directly manages the financial health of regional subsidiaries, ensuring alignment with global corporate objectives. By optimizing local supply chain investments and revenue streams, the Chief Financial Officer (Asia Pacific, Japan) strengthens the market presence of the company. Through strategic financial oversight, the Chief Financial Officer (Asia Pacific, Japan) facilitates the expansion of the product portfolio, ensuring that patients in these regions receive consistent access to essential pharmaceutical treatments.

Craig Olson, the Global Chief Financial Officer, Operations at Teva, directs the financial architecture supporting the massive manufacturing and supply chain infrastructure of the company. By overseeing the cost-efficiency of global production facilities, the Global Chief Financial Officer, Operations ensures that the company maintains a competitive advantage in the generics market. This leadership role involves managing capital expenditures for advanced manufacturing technologies and streamlining the delivery of treatments. Craig Olson directly monitors the financial performance of global operations to ensure alignment with corporate profitability targets. By optimizing inventory management and production costs, the Global Chief Financial Officer, Operations supports the mission of expanding access to quality medicines. Through rigorous financial analysis, the Global Chief Financial Officer, Operations mitigates operational risks and ensures that the manufacturing network remains resilient, scalable, and capable of meeting the global demand for essential pharmaceutical products.

Nishank Bhargava, the Regional Director, Finance & Chief Financial Officer (India) at Teva, directs the financial strategy and operational fiscal management within the Indian market. By overseeing local financial reporting and regulatory adherence, the Regional Director, Finance & Chief Financial Officer (India) ensures that the company maintains a strong foundation for growth in this key manufacturing hub. This leadership role involves managing regional investments to support the development of complex generics and biosimilars. Nishank Bhargava directly coordinates with global leadership to align Indian operations with the broader corporate mission. By optimizing local resource allocation and cost structures, the Regional Director, Finance & Chief Financial Officer (India) enhances the efficiency of the regional business. Through strategic financial planning, the Regional Director, Finance & Chief Financial Officer (India) secures the necessary resources to advance scientific research and improve health outcomes for patients across the region.

Luigi Tiravanti, the Director, Finance & Chief Financial Officer at Teva, directs the financial planning and analysis functions for specific business units to ensure fiscal discipline. By overseeing the development of financial models and performance tracking, the Director, Finance & Chief Financial Officer ensures that the company achieves its strategic objectives regarding profitability and market expansion. This leadership role involves collaborating with department heads to optimize operational budgets and resource utilization. Luigi Tiravanti directly manages the financial health of assigned portfolios, ensuring that all activities support the delivery of innovative therapies. By implementing robust financial controls, the Director, Finance & Chief Financial Officer minimizes waste and maximizes the impact of investments. Through continuous monitoring of financial performance, the Director, Finance & Chief Financial Officer provides the insights necessary for the company to maintain its status as a global biopharmaceutical leader.

Puru Aggarwal, the Board Director and Group Chief Financial Officer, Teva India at Teva, directs the governance and financial oversight of the Indian group operations. By overseeing the alignment of local business strategies with global corporate standards, the Board Director and Group Chief Financial Officer, Teva India ensures that the company maintains high levels of transparency and fiscal responsibility. This leadership role involves participating in board-level decision-making to guide the long-term direction of the Indian business. Puru Aggarwal directly manages the financial health of the group, ensuring that investments in research and manufacturing yield sustainable returns. By optimizing the financial structure of the Indian operations, the Board Director and Group Chief Financial Officer, Teva India supports the broader mission of expanding access to quality medicines. Through strategic leadership, the Board Director and Group Chief Financial Officer, Teva India strengthens the market position of the company.

Dov Primovitch, the Chief Financial Officer (Israel) at Teva, directs the financial operations and fiscal strategy within the headquarters region. By overseeing local budget management and financial planning, the Chief Financial Officer (Israel) ensures that the company maintains a stable foundation for its global activities. This leadership role involves managing the financial aspects of local research and development initiatives to support the creation of cutting-edge therapeutic solutions. Dov Primovitch directly coordinates with global finance teams to ensure consistency in reporting and compliance. By optimizing local operational costs, the Chief Financial Officer (Israel) contributes to the overall efficiency of the company. Through strategic financial oversight, the Chief Financial Officer (Israel) facilitates the advancement of scientific research and ensures that the company remains well-positioned to address unmet patient needs from its primary base of operations.

Yehuda Koren, the Director, Financial & Chief Financial Officer, S L E at Teva, directs the financial management and fiscal oversight for the S L E division. By overseeing the allocation of financial resources and monitoring the performance of specialized therapeutic projects, the Director, Financial & Chief Financial Officer, S L E ensures that the division meets its strategic goals. This leadership role involves analyzing market data to guide investment decisions and improve the profitability of the division. Yehuda Koren directly manages the financial health of the S L E unit, ensuring alignment with the global mission of the company. By optimizing operational processes, the Director, Financial & Chief Financial Officer, S L E enhances the ability of the division to deliver high-quality medicines. Through rigorous financial analysis, the Director, Financial & Chief Financial Officer, S L E supports the long-term growth and success of the company.

Efrat Yehudai, the Senior Vice President, Chief Financial Officer ) Teva Global Operations( ( Tech Operations) at Teva, directs the financial strategy for the technological and operational infrastructure of the company. By overseeing the fiscal management of technical operations, the Senior Vice President, Chief Financial Officer ) Teva Global Operations( ( Tech Operations) ensures that the company invests effectively in the advanced technologies required for modern pharmaceutical manufacturing. This leadership role involves managing the financial aspects of digital transformation and process automation. Efrat Yehudai directly monitors the return on investment for technical upgrades, ensuring that these initiatives support the global production of medicines. By optimizing the financial performance of tech operations, the Senior Vice President, Chief Financial Officer ) Teva Global Operations( ( Tech Operations) enhances the overall efficiency of the company. Through strategic financial oversight, the Senior Vice President, Chief Financial Officer ) Teva Global Operations( ( Tech Operations) ensures that the company remains at the forefront of pharmaceutical innovation.

Alicia Logan, the Chief of Staff & Senior Director, Commercial Excellence at Teva, architects the strategic alignment between executive leadership and commercial operations. By streamlining internal communication and operational workflows, the Chief of Staff & Senior Director, Commercial Excellence ensures that the organization executes its mission of delivering quality medicines with maximum efficiency. This role involves analyzing market trends to refine commercial strategies and improve patient access to pharmacy brands. Alicia Logan directly manages cross-functional projects that enhance the effectiveness of the global sales force. By optimizing commercial processes, the Chief of Staff & Senior Director, Commercial Excellence drives revenue growth and strengthens the market position of the company. Through the implementation of performance metrics, the Chief of Staff & Senior Director, Commercial Excellence maintains high standards of operational excellence across all regional business units, ensuring that the company meets the evolving needs of patients worldwide.